Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (2975)	2/24/2001 3:40:03 PM
From: tuck	Respond to of 52153

Karl Thiel and interviewees attempt to put the # of genes debate in perspective, wondering how relevant it is: doubletwist.com Cheers, Tuck

To: Torben Noerup Nielsen who wrote (2975)	2/24/2001 7:43:49 PM
From: Mark Bong	Read Replies (3) \| Respond to of 52153

Torben, I listened to HGSI's conference call this week. The last point of discussion prior to ending the CC was a rather passionate and clear-cut statement by Dr. Haseltine that that both Celera and the Human Genome Project used faulty analysis to conclude that there are only 30,000 to 40,000 genes. He was emphatic in stating that there are at least 100,000 and probably 120,000. He says that HGSI has identified 20,000, many of which are not included in the CRA/HGP database. Although I do not have the skills or training to know who is right, I would not bet against Dr. Haseltine.